How Ozempic and Wegovy are reshaping Denmark's economy
New York Times: Novo Nordisk’s market value has exceeded the size of the Danish economy.
New York Times: Novo Nordisk’s market value has exceeded the size of the Danish economy.
Financial Times: Antimicrobial resistance already kills millions - and it's getting worse.
MyLifeMatters collective represents over a million patients with life-limiting conditions.
OPINION: Drug-buying agency has received huge criticism. For what?
OPINION: Why your support for the Cancer Society's Daffodil Day matters.
NY Times: Drug makers 'got lucky', experts say - and there's still a lot they don't know.
New York Times: A look at the pills, products and practices that have popped up in 2023.
John Collett moved the methadone to a small bottle, then put it in his pocket.
Telegraph: 'I never expected a licensed drug to make me feel so bad.'
Telegraph: Yes, semaglutide works. But there's a price to pay, says a UK patient.
New York Times: The weight-loss equation changes for older adults, experts say.
Telegraph: A new study points the finger at a little-known hormone called GDF15.
Life Pharmacy and Unichem are having to lower their prices.
The Council of Medical Colleges want to stop the advertisement of medicines.
The dope dozen: the most influential NZ players on the medicinal scene.
BIG READ: Dr Linda Dear labels perimenopause a "blind spot".
Sensitive refurbishment and amalgamation of the buildings takes prize.
Telegraph: Jack Rear started taking finasteride even though he wasn't sure he needed it.
Telegraph: A new doco casts an unflattering light on reproductive healthcare for women.
NZ has reciprocal health agreements with the UK and Oz, National not impressed.
Opinion: Barriers remain after $5 co-payment charge is gone.
Telegraph: Drugs won't solve the world's obesity problem, says Professor Roy Taylor.
The Government has abolished most charges, but some remain.
The decision, announced as part of Budget 2023, will cost the Government $619m.
Medsafe says an audit found a "significant number of non-compliance issues".
Northland women going through menopause are starting to suffer due to an HRT shortage.
Telegraph: Here's everything you need to know about the new anti-fat injections.
Financial Times: Trial results are impressive, but some experts remain sceptical.
Telegraph: A groundbreaking new drug slows symptoms, but early detection is still key.
Telegraph: Insomnia is a growing problem. Here's what you need to know about treatments.